title: Dendritic cell differentiation with prostaglandin E results in selective attenuation of the extracellular signal-related kinase pathway and decreased interleukin-23 production.
abstract: The balance between interleukin (IL)-12 and IL-23 production by dendritic cells (DCs) is crucial for the induction of appropriate immune responses. In the present study, we examined the effect of prostaglandin E(2) (PGE(2)) treatment of DCs during differentiation on IL-12 and IL-23 production in response to Toll-like receptor (TLR) stimulation. Bone marrow-derived DCs were generated by culturing murine bone marrow cells with granulocyte-macrophage colony-stimulating factor (GM-CSF) alone (cont-DCs) or GM-CSF plus PGE(2) (PG-DCs). Upon TLR stimulation, IL-23 production by PG-DCs was markedly decreased compared with that by cont-DCs. However, no significant difference was detected in IL-12 production between these types of DC. To examine the mechanism underlying the impaired production of IL-23 by PG-DCs, we analysed the activities of extracellular signal-related kinases (ERKs) 1/2, p38 mitogen-activated protein kinase (MAPK), c-jun N-terminal kinases 1/2, Akt, and nuclear factor (NF)-kappaB (p65) in these DCs upon TLR stimulation. The ERK1/2 activity in PG-DCs was significantly lower than that of cont-DCs. No significant differences were detected in the activities of other molecules between cont-DCs and PG-DCs. In addition, treatment of cont-DCs with U0126, a specific inhibitor of the ERK pathway, reduced the TLR-mediated production by the DCs of IL-23 but not IL-12. Thus, DC development in the presence of PGE(2) results in selective attenuation of the ERK pathway. The attenuation of ERK activation appears to be responsible for the decreased IL-23 production by PG-DCs.
authors.affiliation: Division of Immunobiology, Research Section of Pathophysiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
authors.forename: Fumie
authors.initials: F
authors.lastname: Hayashi
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Yanagawa
authors.forename: Kazunori
authors.initials: K
authors.lastname: Onoé
authors.forename: Kazuya
authors.initials: K
authors.lastname: Iwabuchi
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells; D002454:Cell Differentiation / Q000187:drug effects*; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000166:cytology* / Q000378:metabolism; D015232:Dinoprostone / Q000494:pharmacology*; D015536:Down-Regulation; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D018664:Interleukin-12 / Q000096:biosynthesis; D053759:Interleukin-23 / Q000096:biosynthesis*; D051379:Mice; D008810:Mice, Inbred C57BL; D019950:Mitogen-Activated Protein Kinase 1 / Q000037:antagonists & inhibitors / Q000378:metabolism; D048052:Mitogen-Activated Protein Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D053759:Interleukin-23; D018664:Interleukin-12; D048049:Extracellular Signal-Regulated MAP Kinases; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3; D015232:Dinoprostone
references.citation: Cell Immunol. 2009;258(1):9-17
references.pmid: 19361784
references.citation: J Pharmacol Exp Ther. 1996 Jun;277(3):1793-800
references.pmid: 8667251
references.citation: Immunol Rev. 2000 Oct;177:134-40
references.pmid: 11138771
references.citation: Blood. 2007 Dec 15;110(13):4293-302
references.pmid: 17699744
references.citation: Mol Immunol. 2008 May;45(10):2734-42
references.pmid: 18372043
references.citation: Annu Rev Immunol. 2009;27:485-517
references.pmid: 19132915
references.citation: J Immunol. 2007 Aug 1;179(3):1497-505
references.pmid: 17641015
references.citation: Am J Transplant. 2007 Feb;7(2):278-84
references.pmid: 17229073
references.citation: Science. 1999 Dec 10;286(5447):2098-102
references.pmid: 10617422
references.citation: J Immunol. 2003 Nov 15;171(10):4984-9
references.pmid: 14607893
references.citation: J Immunol. 1996 Jan 1;156(1):5-7
references.pmid: 8598493
references.citation: J Leukoc Biol. 2002 Jan;71(1):125-32
references.pmid: 11781388
references.citation: J Immunol. 1997 Jun 1;158(11):5507-13
references.pmid: 9164974
references.citation: Blood. 2001 Oct 1;98(7):2175-82
references.pmid: 11568005
references.citation: Nature. 2006 May 11;441(7090):235-8
references.pmid: 16648838
references.citation: J Immunol. 2000 Jul 15;165(2):618-22
references.pmid: 10878331
references.citation: Curr Opin Immunol. 2005 Aug;17(4):338-44
references.pmid: 15950447
references.citation: Trends Mol Med. 2007 Nov;13(11):460-9
references.pmid: 18029230
references.citation: J Immunol. 1997 Jun 1;158(11):5501-6
references.pmid: 9164973
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: Annu Rev Immunol. 1991;9:271-96
references.pmid: 1910679
references.citation: Nat Immunol. 2005 Nov;6(11):1133-41
references.pmid: 16200068
references.citation: J Biol Chem. 2001 Oct 5;276(40):37692-9
references.pmid: 11477091
references.citation: J Exp Med. 1992 Dec 1;176(6):1693-702
references.pmid: 1460426
references.citation: Eur J Immunol. 1999 Jul;29(7):2360-5
references.pmid: 10427999
references.citation: Dev Immunol. 1992;2(4):263-71
references.pmid: 1364176
references.citation: Nat Immunol. 2002 Jan;3(1):69-75
references.pmid: 11743587
references.citation: J Biol Chem. 2007 Apr 20;282(16):11613-7
references.pmid: 17329241
references.citation: Immunol Today. 1991 Oct;12(10):349-52
references.pmid: 1958288
references.citation: Nat Med. 2007 Feb;13(2):139-45
references.pmid: 17290272
references.citation: Nat Immunol. 2002 Sep;3(9):875-81
references.pmid: 12154357
references.citation: Nat Rev Immunol. 2008 Jan;8(1):81-6
references.pmid: 18084185
references.citation: Trends Immunol. 2002 Mar;23(3):144-50
references.pmid: 11864843
references.citation: Nature. 2006 May 11;441(7090):231-4
references.pmid: 16648837
references.citation: J Immunol. 1994 May 1;152(9):4282-90
references.pmid: 7512590
references.citation: FASEB J. 1995 Aug;9(11):1051-8
references.pmid: 7649404
references.citation: J Immunol. 2007 May 15;178(10):6173-80
references.pmid: 17475844
references.citation: FASEB J. 2004 Aug;18(11):1318-20
references.pmid: 15180965
references.citation: J Immunol. 2008 Jul 1;181(1):721-35
references.pmid: 18566439
references.citation: Chem Immunol Allergy. 2006;90:82-90
references.pmid: 16210904
references.citation: J Immunol. 2007 Jun 15;178(12):8138-47
references.pmid: 17548652
references.citation: Blood. 1997 Nov 1;90(9):3245-87
references.pmid: 9345009
references.citation: Nat Immunol. 2005 Nov;6(11):1123-32
references.pmid: 16200070